Mark Anthony Kerry
3Patents
0h-index
24Co-inventors
31Inventor score
Filing activity: Sep 30, 2016 → Oct 5, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11091428B2 | Antiviral compounds | Emerging Cross-Sectional Technologies | 0 | Active |
| US11180479B2 | Antiviral compounds | Chemistry; Metallurgy | 0 | Active |
| US9963462B2 | Sepiapterin reductase inhibitors | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.